Literature DB >> 15382286

MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease.

Russell H Wiesner1.   

Abstract

1. Historical perspective of donor allocation to patients with fulminant hepatic failure (FHF). 2. Predicting prognosis in patients with FHF using the London and Clichy criteria. 3. Model for end-stage liver disease (MELD) is a predictor of mortality in patients with FHF. 4. Outcomes of adults listed as Status 1 in the United States. 5. Outcomes of pediatric candidates listed as Status 1 in the United States. 6. Proposed redefinition for Status 1 in adult and pediatric candidates.

Entities:  

Mesh:

Year:  2004        PMID: 15382286     DOI: 10.1002/lt.20273

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

1.  Pediatric chronic liver failure-sequential organ failure assessment score and outcome of acute liver failure in children.

Authors:  Bassam Abdel Hakam Ayoub; Mohammed Abdel Hafez Ali; Tahany Abdel Hamid Salem; Marwa Sabry Rizk; Salma Abdel Megeed Nagi; Nermin Mohammed Adawy
Journal:  Clin Exp Hepatol       Date:  2020-09-18

Review 2.  Acute liver failure including acetaminophen overdose.

Authors:  Robert J Fontana
Journal:  Med Clin North Am       Date:  2008-07       Impact factor: 5.456

3.  Liver transplantation for acute hepatic failure.

Authors:  Eric T Castaldo; Ravi S Chari
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 4.  Management of early hepatic artery occlusion after liver transplantation with failed rescue.

Authors:  Chih-Yang Hsiao; Cheng-Maw Ho; Yao-Ming Wu; Ming-Chih Ho; Rey-Heng Hu; Po-Huang Lee
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

5.  The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Naoki Kawagishi; Noriatsu Kanno; Yoko Yamagiwa; Koji Fukushima; Susumu Satomi; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2006-11-09       Impact factor: 6.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.